Los Angeles Capital Management LLC Grows Stock Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Los Angeles Capital Management LLC grew its position in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 30.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 64,467 shares of the real estate investment trust’s stock after buying an additional 14,925 shares during the period. Los Angeles Capital Management LLC’s holdings in Sabra Health Care REIT were worth $1,117,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. JPMorgan Chase & Co. lifted its holdings in Sabra Health Care REIT by 222.4% during the third quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust’s stock valued at $183,996,000 after purchasing an additional 6,819,919 shares during the last quarter. Wellington Management Group LLP raised its position in shares of Sabra Health Care REIT by 736.5% in the third quarter. Wellington Management Group LLP now owns 2,396,835 shares of the real estate investment trust’s stock valued at $44,605,000 after purchasing an additional 2,110,307 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Sabra Health Care REIT by 324.3% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,404,576 shares of the real estate investment trust’s stock valued at $26,139,000 after buying an additional 1,073,530 shares in the last quarter. Thrivent Financial for Lutherans boosted its holdings in Sabra Health Care REIT by 1,557.9% in the 3rd quarter. Thrivent Financial for Lutherans now owns 927,309 shares of the real estate investment trust’s stock worth $17,258,000 after buying an additional 871,375 shares during the period. Finally, FMR LLC grew its stake in Sabra Health Care REIT by 89.7% in the 3rd quarter. FMR LLC now owns 1,599,532 shares of the real estate investment trust’s stock valued at $29,767,000 after buying an additional 756,418 shares in the last quarter. Institutional investors own 99.40% of the company’s stock.

Sabra Health Care REIT Price Performance

Shares of NASDAQ SBRA opened at $16.61 on Friday. The firm has a market capitalization of $3.95 billion, a P/E ratio of 31.34, a P/E/G ratio of 1.97 and a beta of 1.25. The company has a quick ratio of 4.16, a current ratio of 4.32 and a debt-to-equity ratio of 0.88. The stock’s 50-day simple moving average is $16.77 and its two-hundred day simple moving average is $17.62. Sabra Health Care REIT, Inc. has a twelve month low of $13.31 and a twelve month high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA) last announced its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.36. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. The business had revenue of $182.35 million for the quarter, compared to the consensus estimate of $178.01 million. As a group, equities analysts anticipate that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Friday, February 14th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 7.22%. The ex-dividend date was Friday, February 14th. Sabra Health Care REIT’s dividend payout ratio is currently 226.42%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. Citizens Jmp upgraded Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 7th. Truist Financial downgraded Sabra Health Care REIT from a “buy” rating to a “hold” rating and cut their target price for the stock from $18.00 to $17.00 in a research note on Friday, January 17th. Mizuho reiterated a “neutral” rating and set a $20.00 price target on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. Finally, JMP Securities upgraded shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective for the company in a research report on Tuesday, January 7th. Three equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Sabra Health Care REIT presently has an average rating of “Moderate Buy” and an average target price of $19.17.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.